At the news
? NEUTRALIMPACT 3/10 DEFA14A filed Mar 16, 2026 at 16:04 ET
Lexicon Pharmaceuticals, Inc. has filed a definitive additional materials proxy statement (DEFA14A) related to a shareholder vote. The filing appears to be routine and does not contain material financial information or indicate an activist campaign.
- Filing is a DEFA14A, which is a definitive additional materials proxy statement.
- The filing is routine and does not contain material financial data.
- No activist campaign or significant corporate action is indicated in the available documents.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access